NEO

#1894
NeoGenomics, Inc. - Common Stock
10.5 2 USD
+3.14%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
10.52
10.52
년간 변동
4.72
13.74
일일 변동
+3.14%
월간 변동
+16.11%
6달 변화
-12.33%
년간 변동율
+42.93%
이전 종가
10.2 0
Open
10.5 2
저가
10.5 2
High
10.5 2
양
154
전체 차트 열기 Full chart

Financials

개요 성명 통계
4분기 연간
  • Market Capitalization 1.37 B
  • Employee 2 500
  • Founded 2002
  • CEO Christopher M. Smith
  • Website www.neogenomics.com
  • Headquarter Nevada, United States
  • FIGI BBG000BKH263
  • Industry 분석 & 리서치
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
-13.95
주가매출액비율
2.07

NeoGenomics, Inc. - Common Stock

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

뉴스